Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
If you have any interest in pharmaceuticals, then you can “bank” on the fact that you’ll find DrugBank to be a fantastic resource. Of the “molecule-target interaction” variety, DrugBank is different from many of the other databases out there in its emphasis on pharmaceutical data. It contains FDA-approved biotech (protein/peptide) drugs, FDA-approved small molecule drugs, and a large number of experimental drugs. Together, these categories represent over 10,000 entries. As useful as it is to search databases, I always appreciate an option to browse. DrugBank, in fact, gives me (and you!) six such options: browse by drug name, therapeutic category, interacting gene/enzyme, pathway, chemical class, or association (target, enzyme, carrier, or transporter). For each compound, general chemical information is provided in addition to taxonomy, pharmacology, pharmacoeconomics, references, drug interactions, and targets.